As a protective factor, increased expression of SLC10A2 is closely related to suppression of NSCLC cell proliferation and migration, and promote apoptosis under bexarotene treatment (Ai et al., 2018). The gene discussed is SLC10A2; the disease is non-small cell lung carcinoma.